MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
BIO Bio-Rad Laboratories
- 327.470
- +1.530+0.47%
Close Dec 20 16:00 ET
- 327.470
- 0.0000.00%
Post 16:15 ET
9.17BMarket Cap-11.66P/E (TTM)
334.100High325.720Low691.29KVolume325.720Open325.940Pre Close226.58MTurnover3.56%Turnover RatioLossP/E (Static)28.00MShares387.99052wk High1.22P/B6.36BFloat Cap262.12052wk Low--Dividend TTM19.43MShs Float832.700Historical High--Div YieldTTM2.57%Amplitude9.438Historical Low327.760Avg Price1Lot Size
Bio-Rad Laboratories Key Stats
EPS
According to the latest financial report of Bio-Rad Laboratories, the latest earnings per share (TTM) for the company is 23.34. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Bio-Rad Laboratories's free cash flow? The latest report shows it as 99.97M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Bio-Rad Laboratories shows that the company's current ratio is 6.14, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Bio-Rad Laboratories, the quick ratio is 4.19, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Bio-Rad Laboratories? The latest ROE figure is 9.16%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Bio-Rad Laboratories, the total asset return on investment (ROA) is 6.44%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Bio-Rad Laboratories's latest financial report to see how their gross margin is doing - currently at 54.78%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Bio-Rad Laboratories, the net profit margin is 100.53%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.